CUSIP 107924102COM NEWBBOTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
53 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 17.88M | $223.84M | 0 | Held |
| 2 | Deerfield Management Company, L.P. | 4.89M | $61.17M | 0 | Held |
| 3 | Omega Fund Management, LLC | 3.29M | $41.19M | 0 | Held |
| 4 | Wellington Management Group LLP | 2.91M |
| $36.40M |
| −54.3K |
| Reduced |
| 5 | Ecor1 Capital, LLC | 2.82M | $35.35M | 0 | Held |
| 6 | Alphabet Inc. | 2.82M | $35.35M | 0 | Held |
| 7 | Enavate Sciences Gp, LLC | 2.63M | $32.89M | 0 | Held |
| 8 | Citadel Advisors LLC | 2.53M | $31.68M | −7.8K | Reduced |
| 9 | Catalio Capital Management, LP | 410.7K | $31.41M | +410.7K | New |
| 10 | Paradigm Biocapital Advisors LP | 2.26M | $28.32M | +395.6K | Added |
See every fund holding Bridgebio Oncology Therapeut, with full quarter-over-quarter share changes.
Unlock all holders